Companies
-
Together again: Celgene A-team reunites
- 07 Apr 2021
Six execs are back together with the newest kid on the blood cancer block, start-up biopharma Antengene, backing its first market entry with their decades of experience.
Read more -
Lilly moves on migraine
- 25 Mar 2021
Has submitted Emgality pricing application consistent with PBAC recommendation, Senate Estimates told.
Read more -
J&J ref kicks new career goal
- 24 Mar 2021
Jonathon Moore is one of only four internationally accredited futsal referees in Australia but this J&J comms expert just kicked a big career goal.
Read more -
GSK shingles vax coming to Aus
- 24 Mar 2021
EXCLUSIVE: Blockbuster shingles vaccine to be available on private script mid-year but GSK says don’t expect funded access before at least 2024.
Read more -
Diabetes class offers fivefold return
- 24 Mar 2021
New Australian report finds investment in SGLT2 inhibitors would deliver a strong return.
Read more -
BioMarin MD speaks on leadership
- 22 Mar 2021
Kathryn Evans explains how gender diversity at the top is good for business.
Read more -
Revlimid exclusivity under threat
- 22 Mar 2021
Court expedites trial for first competitor challenge to BMS’ blood cancer drug.
Read more -
Zimmerman heads for Melbourne
- 19 Mar 2021
CAR-T cell therapy likely to be a focus as parliamentary inquiry holds Melbourne hearings in April.
Read more